<p>In A, chondrocytes were pretreated with anti-RAGE (5 μg/ml) for 12 hours before AGEs (100 μg/ml) stimulation. In B, chondrocytes were pretreated with SB203580, SP600125, PD98059 (10 μM) for 30 minutes prior to AGEs (100 μg/ml) stimulation. The expression of PPARγ was quantified by real-time PCR and western blotting using β-actin as an internal control. In A, densitometric analysis for PPARγ levels corrected to β-actin is shown. All data are expressed as means ± SD and are representative of three independent experiments. *: <i>p< 0</i>.<i>05</i> versus control, #: <i>p< 0</i>.<i>05</i> versus AGEs treatment, &: <i>p> 0</i>.<i>05</i> versus AGEs treatment.</p
<p><b>Copyright information:</b></p><p>Taken from "Contrasting effects of peroxisome-proliferator-ac...
<p>Primary human chondrocytes were incubated with AGEs (1 to 100 μg/ml). The expression of IL-1α, IL...
SummaryObjectivePeroxisome proliferator activated receptor α (PPARα) agonists are used in clinical p...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were treated with AGEs (5–100 µg/ml) for 24 hours (A)...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for 0.5–24 hours ...
Accumulation of advanced glycation end products (AGEs) in joints is important in the development of ...
<p>The proposed schematic representation of AGEs-induced inflammatory signalings and resulted reduct...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for indicated tim...
Accumulation of advanced glycation end products (AGEs) in joints is important in the development of ...
<p><b>Copyright information:</b></p><p>Taken from "Peroxisome proliferator-activated receptor γ1 exp...
<p><b>Copyright information:</b></p><p>Taken from "Contrasting effects of peroxisome-proliferator-ac...
<p>Human OA chondrocytes (1 ×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for 0.5–24 hours...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were pretreated with pioglitazone (10 and 50 µg/ml) f...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (5–100 µg/ml) for 24 hours (...
This dissertation describes a new model in which cartilage degradation can be studied. New cartilage...
<p><b>Copyright information:</b></p><p>Taken from "Contrasting effects of peroxisome-proliferator-ac...
<p>Primary human chondrocytes were incubated with AGEs (1 to 100 μg/ml). The expression of IL-1α, IL...
SummaryObjectivePeroxisome proliferator activated receptor α (PPARα) agonists are used in clinical p...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were treated with AGEs (5–100 µg/ml) for 24 hours (A)...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for 0.5–24 hours ...
Accumulation of advanced glycation end products (AGEs) in joints is important in the development of ...
<p>The proposed schematic representation of AGEs-induced inflammatory signalings and resulted reduct...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for indicated tim...
Accumulation of advanced glycation end products (AGEs) in joints is important in the development of ...
<p><b>Copyright information:</b></p><p>Taken from "Peroxisome proliferator-activated receptor γ1 exp...
<p><b>Copyright information:</b></p><p>Taken from "Contrasting effects of peroxisome-proliferator-ac...
<p>Human OA chondrocytes (1 ×10<sup>6</sup>/ml) were incubated with AGEs (50 µg/ml) for 0.5–24 hours...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were pretreated with pioglitazone (10 and 50 µg/ml) f...
<p>Human OA chondrocytes (1×10<sup>6</sup>/ml) were incubated with AGEs (5–100 µg/ml) for 24 hours (...
This dissertation describes a new model in which cartilage degradation can be studied. New cartilage...
<p><b>Copyright information:</b></p><p>Taken from "Contrasting effects of peroxisome-proliferator-ac...
<p>Primary human chondrocytes were incubated with AGEs (1 to 100 μg/ml). The expression of IL-1α, IL...
SummaryObjectivePeroxisome proliferator activated receptor α (PPARα) agonists are used in clinical p...